Loading…

Effects of novel 17-azolyl compounds on androgen synthesis in vitro and in vivo

17-Azolyl steroids were synthesized and evaluated as inhibitors of androgen synthesis in vitro and in vivo. Several of the novel compounds exhibit potent noncompetitive inhibition of human 17α-hydroxylase/C 17,20-lyase with IC 50 values ranging from 7 to 90 nM, and K i values from 1.2 to 41 nM. VN/8...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of steroid biochemistry and molecular biology 1999-12, Vol.71 (3), p.145-152
Main Authors: Nnane, I.P., Njar, V.C.O., Liu, Y., Lu, Q., Brodie, A.M.H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:17-Azolyl steroids were synthesized and evaluated as inhibitors of androgen synthesis in vitro and in vivo. Several of the novel compounds exhibit potent noncompetitive inhibition of human 17α-hydroxylase/C 17,20-lyase with IC 50 values ranging from 7 to 90 nM, and K i values from 1.2 to 41 nM. VN/85-1 and VN/108-1 were the most potent inhibitors against this enzyme with IC 50 value of 8 nM ( K i of 1.2 nM) and 7 nM ( K i of 1.9 nM), respectively. VN/107-1, VN/108-1 and VN/109-1 also showed moderate inhibition of 5α-reductase in human prostatic microsomes. Normal adult male rats were treated with these novel 17-azolyl steroidal compounds at a dose level of 50 mg/kg, s.c., for 14 consecutive days, sacrificed 1–2 h after the last administered dose and blood, prostate and other tissues were collected. The organs were weighed and tissue concentrations of testosterone (T) and dihydrotestosterone (DHT) were measured. Tissue T levels were significantly ( p
ISSN:0960-0760
1879-1220
DOI:10.1016/S0960-0760(99)00129-6